Submissions are open for the upcoming issue.

Molecular Medicine Peer-reviewed scientific journal

Found: 6

ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 30–38

Serotonin, 5-HIAA, and membrane serotonin transporter in blood as biomarkers of familial hypercholesterolemia in immature low-density lipoprotein receptor-deficient mice

Introduction. Cardiovascular diseases are the main cause of death and disability in the world population. Serotonin plays a significant role in the development and progression of atherosclerotic processes due to its two classical functions – platelet aggregati…

10.29296/24999490-2025-04-05Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022 · pp. 34–41

EFFECTIVENESS OF α1А-ADRENORECEPTOR ANTAGONIST IN THE PASSAGE OF MIDDLE STONES FROM THE URETER: THE ROLE OF RECEPTORS COUPLED WITH G-PROTEIN

The study aims to analyze the dependence of an α1А-adrenoreceptor antagonist effectiveness on G-protein-coupled receptors (GPCRs) intracellular signaling in the passage of medium-sized calculi from the ureter. Material and methods. The study was prospective an…

10.29296/24999490-2022-05-05Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022 · pp. 43–49

SIGNAL TRANSDUCTION OF INEFFICIENT ELIMATION OF SMALL STONES FROM THE MIDDLE THIRD OF THE URETER

Аim of the study was to evaluate the activity of receptors that control contraction (α2-adrenergic receptor, purine P2X1 and P2Y receptors, angiotensin AT1 receptor, TxA2 receptor) and relaxation of smooth myocytes (adenosine A2 receptor) during standard litho…

10.29296/24999490-2022-04-07Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022 · pp. 45–52

PURINERGIC REGULATION OF STONES ELIMINATION FROM THE UPPER PARTOF THE URETER DURING LITHOKINETIC THERAPY

The reasons for the low efficiency of the α1A-blockers using in the scheme of lithokinetic therapy (LCT) remain unclear. The aim of the study was to evaluate the activity of the purinergic P2X1 receptor in the blockade of the α1A-adrenergic receptor during LCT…

10.29296/24999490-2022-02-07Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015

MOLECULAR MODELING, SYNTHESIS AND EVALUATION OF THE BIOLOGICAL ACTIVITY OF MODERN HETEROMEROUS PEPTIDES WITH IMIDAZO[4,5-Е]BENZO[1,2-C;3,4-C’]DIFUROXAN FRAGMENT AS NEW INHIBITORS OF PLATELET AGGREGATION

Introduction. Cardiovascular diseases consistently occupy the first place among causes of death and disability in almost all developed countries. The main importance of this group of diseases have myocardial infarction. One of the causes of myocardial infarcti…

Details ↗
Research article2013

MOLECULAR MODELING, SYNTHESIS AND EVALUATION OF THE BIOLOGICAL ACTIVITYOF NEW GLYCOPROTEIN IIB/IIIA (GPIIB/IIIA) RECEPTOR ANTAGONISTS

We applied software «Algokomb» to perform mathematical modeling of polypeptide molecules of glycoprotein IIb/IIIa (gpIIb/IIIa) receptor antagonists. The modeled compounds have been synthesized accordingly to the protocol of strategy FastMoc 0.25. The structure…

Details ↗ PDF

Article search and quick navigation

Navigation